Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

141 public trials 49 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Recruiting

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

NCT07217587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Neurology Center of North Orange County Fullerton, California, United States
  • The Neurology Group Pomona, California, United States
  • Advanced Neurology of Colorado Fort Collins, Colorado, United States
  • University of Connecticut Farmington, Connecticut, United States
View all 17 locations
View Trial Details
Recruiting

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

NCT06414954

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Profound Research LLC Carlsbad, California, United States
  • University of California Irvine Medical Center Irvine, California, United States
  • University of Colorado Neuromuscular Division Aurora, Colorado, United States
  • SFM Clinical Research, LLC Boca Raton, Florida, United States
View all 40 locations
View Trial Details
Recruiting

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

NCT07294170

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
View all 30 locations
View Trial Details
Recruiting

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

NCT07284420

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +15 more
Locations
  • Profound Research LLC - Carlsbad Carlsbad, California, United States
  • Visionary Investigators Network Miami, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Henry Ford Health Systems Detroit, Michigan, United States
View all 27 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)

NCT07673744

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • TG Therapeutics Investigational Trial Site Colorado Springs, Colorado, United States
  • TG Therapeutics Investigational Trial Site Clearwater, Florida, United States
  • TG Therapeutics Investigational Trial Site Colorado Springs, Colorado, United States
  • TG Therapeutics Investigational Trial Site Farmington Hills, Michigan, United States
View Trial Details
Recruiting

AXIS MG Patient Registry

NCT07761026

Conditions
AChR Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, +34 more
Locations
  • Alira Health - Virtual/Remote Site - Can Be Completed 100% Online - All US Residents Accepted Framingham, Massachusetts, United States
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details

Related conditions